Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Med Imaging Radiat Oncol ; 66(5): 637-640, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34524723

ABSTRACT

Mucinous prostate adenocarcinoma represents <0.1% of prostate cancers. To our knowledge, no previous report has described the 68 Ga-PSMA-PET characteristics of this entity at the primary site. We present a case of a fit 85-year-old with PSA 0.55 ng/mL and ISUP grade 4 acinar adenocarcinoma with mucinous features on biopsy. 68 Ga-PSMA-PET revealed an intensely avid primary lesion in the right prostate (SUVmax 10.9), concordant with biopsy findings and encompassing both the PI-RADS 5 lesion identified on MRI and a PI-RADS 1 lesion that presumably represented the mucinous component. The patient was treated with definitive radiotherapy to the prostate and lymph nodes with 6 months of androgen deprivation therapy.


Subject(s)
Adenocarcinoma , Prostatic Neoplasms , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/radiotherapy , Aged, 80 and over , Androgen Antagonists , Edetic Acid , Gallium Radioisotopes , Humans , Magnetic Resonance Imaging , Male , Oligopeptides , Positron Emission Tomography Computed Tomography , Prostate/pathology , Prostate-Specific Antigen , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/pathology , Prostatic Neoplasms/radiotherapy
SELECTION OF CITATIONS
SEARCH DETAIL